Poster Presentation ESA-SRB Conference 2015

Radioactive Iodine ablation of differentiated Thyroid cancer as per 2009 ATA guidelines and future directions: single centre experience –retrospective review. (#247)

Divya Srivastava 1 , David Jesudason 2 , Frank Zhang 3 , Venkat Vangaveti 4 , Gabrielle Cehic 1 , Steven Unger 1 , Michael Kitchener 1
  1. Nuclear Medicine , The Queen Elizabeth Hospital, Adelaide, South Australia
  2. Endocrinology, The Queen Elizabeth Hospital, Adelaide, South Australia, Australia
  3. University of Adelaide, Adelaide, South Australia
  4. School of Medicine and Dentistry, James Cook University, Townsville, Qld, Australia
Publish consent withheld
  1. Cooper, D.S., et al., Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid, 2009. 19(11): p. 1167-1214.
  2. Brown, A.P., et al., The Risk of Second Primary Malignancies up to Three Decades after the Treatment of Differentiated Thyroid Cancer. The Journal of Clinical Endocrinology & Metabolism, 2008. 93(2): p. 504-515.
  3. Iyer, N.G., Morris, L. G. T., Tuttle, R. M., Shaha, A. R. and Ganly, I., Rising incidence of second cancers in patients with low-risk (T1N0) thyroid cancer who receive radioactive iodine therapy. Cancer, 2011.
  4. Kukulska, A., et al., Radioiodine thyroid remnant ablation in patients with differentiated thyroid carcinoma (DTC): prospective comparison of long-term outcomes of treatment with 30, 60 and 100 mCi. Thyroid Research, 2010. 3(1): p. 9.
  5. Lamartina, L., et al., Low-Risk Differentiated Thyroid Cancer and Radioiodine Remnant Ablation: A Systematic Review of the Literature. The Journal of Clinical Endocrinology & Metabolism, 2015. 100(5): p. 1748-1761.
  6. Londero, S.C., et al., Papillary Thyroid Carcinoma in Denmark, 1996–2008: Outcome and Evaluation of Established Prognostic Scoring Systems in a Prospective National Cohort. Thyroid, 2014. 25(1): p. 78-84.
  7. Miyauchi, A., et al., Prognostic Impact of Serum Thyroglobulin Doubling-Time Under Thyrotropin Suppression in Patients with Papillary Thyroid Carcinoma Who Underwent Total Thyroidectomy. Thyroid, 2011. 21(7): p. 707-716.
  8. Verburg, F.A., et al., Long-Term Survival in Differentiated Thyroid Cancer Is Worse After Low-Activity Initial Post-Surgical 131I Therapy in Both High- and Low-Risk Patients. The Journal of Clinical Endocrinology & Metabolism, 2014. 99(12): p. 4487-4496.
  9. Franceschi, M., et al., Thyroglobulin Determination, Neck Ultrasonography and Iodine-131 Whole-Body Scintigraphy in Differentiated Thyroid Carcinoma. Journal of Nuclear Medicine, 1996. 37(3): p. 446-451.